New therapeutic targets and biomarkers for acute graft-versus-host disease (GVHD)

Keyphrases

• Action Targets 12%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 12%
• Area Cover 12%
• Avoid Risk 12%
• Cell Survival 12%
• Clinical Grading 12%
• Clinical High Risk 12%
• Clinical Trials 12%
• Disease Treatment 12%
• Emerging Therapeutics 12%
• Expert Opinion 12%
• Gastrointestinal Tract 25%
• Grading System 12%
• Graft-versus-host Disease (GvHD) 100%
• Host Treatment 12%
• Immunosuppression 12%
• Infection Risk 12%
• Integrin Receptor 12%
• JAK Signaling 12%
• Mechanism of Action 12%
• New Drug Targets 100%
• Pathophysiologic 12%
• Patient Response 12%
• Patient's Will 25%
• PubMed 12%
• Refractory Patients 12%
• Relapse Risk 12%
• Response to Therapy 12%
• Risk-adapted Therapy 12%
• Search Keywords 12%
• Search Terms 12%
• Selective Targeting 12%
• Steroid-refractory 12%
• Systemic Steroids 12%
• T Cells 12%
• Target Organ 12%
• Therapeutic Biomarkers 100%
• Therapeutic Target 25%

Immunology and Microbiology

• Acute Graft Versus Host Disease 100%
• Cell Survival 20%
• Cell Transplantation 20%
• Gastrointestinal Tract 40%
• Graft-Versus-Host Disease 80%
• Hematopoietic Cell 20%
• Immunosuppression 20%
• Infection 20%
• Integrin 20%
• T Cell 20%
• Target Cell 20%
• Target Organ 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Graft Versus Host Disease 100%
• Biological Marker 100%
• Clinical Trial 20%
• Combination Therapy 20%
• Graft Versus Host Reaction 40%
• Infection 20%
• Integrin Receptor 20%